Image of Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure

LITERATURE

Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure


Diabetes is a risk factor for heart failure, and both conditions are increasing. Identifying treatments that
prevent both conditions will be clinically important. We previously reported that candesartan (an angiotensin receptor
blocker) reduces cardiovascular mortality and heart failure hospitalizations in heart failure patients (CHARM:
Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity Program).


Availability

Canderin-002Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Circulation. 2005;112:48-53
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous